Home Tools
Log in
Cart

Search Result

Search Results for " cbp-in-1 "

18

Compounds

Cat No. Product Name Synonyms Targets
T79168 CBP-IN-1 Epigenetic Reader Domain
CBP-IN-1 (compound 12) acts as a potent CBP inhibitor exhibiting an IC50 of 1.5 nM and additionally suppresses CBP BRET and BRD4(1) with IC50 values of 690 nM and 3100 nM, respectively [1].
T7264 CBP/EP300-IN-1 Epigenetic Reader Domain
CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
T10717 Inobrodib CBP-IN-1 Epigenetic Reader Domain
Inobrodib (CBP-IN-1) is a potent inhibitor of p300/CBP bromodomain.
T12537 β-catenin/CBP-IN-1 Wnt/beta-catenin
β-catenin/CBP-IN-1 is a potent and selective inhibitor of CBP/β-catenin
T15405 GNE-781 Epigenetic Reader Domain
GNE-781 is a highly potent and selective inhibitor of CBP (IC50: 0.94 nM in TR-FRET assay). GNE-781 also inhibits BRET and BRD4(1) (IC50s: 6.2 nM and 5100 nM, respectively).
T4247 I-CBP112 hydrochloride Epigenetic Reader Domain
I-CBP112 is a selective inhibitor of the bromodomain-containing transcription factors. I-CBP112 (1 mM) has little activity against other bromodomains. I-CBP112 targets the CBP/p300 bromodomains. I-CBP112 significantly re...
TN1567 Delphinidin chloride Estrogen Receptor/ERR , VEGFR
Delphinidin chloride, a natural plant pigment found in berries and red wine, is a precursor of certain anthocyanins. Delphinidin chloride induces the release of nitric oxide from the vascular endothelium, resulting in va...
T39826 CBP/p300-IN-8 CBP/p300-IN-8
CBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 μΜ) and BRD4 ( IC 50 =1-1000 μΜ) activity.
T15399 GNE-207 Epigenetic Reader Domain
GNE-207 is a selective and orally bioavailable inhibitor of the bromodomain of CBP (IC50: 1 nM). It has a selective index of >2500-fold against BRD4 (1). GNE-207 displays excellent CBP potency (EC50: 18 nM for MYC expres...
T62700 CBP/p300-IN-16
CBP/p300-IN-16 (compound 1) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.61 μM) and LK2 H3K27 (IC50: 2.24 μM).
T40143 PROTAC CBP/P300 Degrader-1 PROTAC CBP/P300 Degrader-1
PROTAC CBP/P300 Degrader-1 is an effective compound that degrades CBP/P300 in a potent manner. It significantly reduces cell viability in various cancer cell lines.
T79395 CBP/p300-IN-21 Epigenetic Reader Domain
CBP/p300-IN-21 (Compound 5d), a selective inhibitor of CBP/p300 with IC50 values of 0.07 μM for p300 and 1.755 μM for CBP, reduces H3K18Ac levels and inhibits the growth of 4T1 tumors in mice [1].
T15397 GNE-049 Epigenetic Reader Domain
GNE-049 is a highly potent and selective inhibitor of CBP (IC50: 1.1 nM in TR-FRET assay). GNE-049 also inhibits BRET and BRD4(1) (IC50s: 12 nM and 4200 nM, respectively).
T40036 Thalidomide-NH-PEG4-COOH Thalidomide-NH-PEG4-COOH
Thalidomide-NH-PEG4-COOH is a conjugate comprising an E3 ligase ligand-linker, utilized in the synthesis of dCBP-1. dCBP-1 itself functions as a powerful and selective heterobifunctional degrader targeting p300/CBP.
T79230 JET-209 PROTACs
JET-209 is a potent proteolysis-targeting chimera (PROTAC) that effectively degrades CBP/p300, exhibiting half-maximal degradation concentration (DC50) values of 0.05 nM for CBP and 0.2 nM for p300. The compound comprise...
T74823 Bromodomain IN-2
BD-IN-1, a pan bromodomain (BD) inhibitor, exhibits K_D values of 250 nM for BRD4(1), 420 nM for CBP, 130 nM for BRPF1B, 430 nM for BRD7, 67 nM for BRD9, 240 nM for BRDT(1), and 970 nM for CECR2, respectively. This compo...
T81314 Rademikibart CBP-201
Rademikibart (CBP-201) is a human monoclonal antibody selective for IL-4Rα, exhibiting strong affinity with a KD of 20.7 pM for human IL-4Rα epitopes, without cross-reactivity to IL-4Rα from other species. It effectively...
T69014 Sekikaic Acid
Sekikaic acid is a phenolic lichen metabolite that has been found in H. obscurata and has diverse biological activities. It scavenges superoxide and DPPH radicals in cell-free assays when used at a concentration of 0.5 µ...
TargetMol